Shop by goal
Popular compounds
Research resources
Recently viewed
Is TB-500 FDA Approved? The 2026 Regulatory Status, Explained
Short answer: no. TB-500 is not an FDA-approved drug. It is a synthetic peptide related to thymosin beta-4, supplied strictly as a research-use-only compound, not for human consumption. TB-500 is on the FDA’s July 23, 2026 compounding advisory committee agenda (evaluated use: wound healing) — a review of possible 503A Bulks List inclusion, which is not drug approval. It is also prohibited in tested sport by WADA.
Like its frequent companion BPC-157, TB-500 is widely discussed in recovery and tissue-repair circles — and just as often misunderstood when it comes to its regulatory status. The short answer to “is TB-500 FDA approved?” is no. Here is the fuller picture, including the July 2026 FDA review and the sport-doping angle.
What “FDA approved” actually means
FDA approval requires a sponsor to submit a New Drug Application backed by Phase I–III clinical trials, manufacturing controls and a characterised safety profile, after which the FDA decides whether the drug is safe and effective for a specific indication. TB-500 has not been through that process — there is no approved application and no completed Phase III programme. For the compounds that have cleared that bar, see our FDA peptide approval pipeline guide.
Is TB-500 FDA approved? The current status
No. TB-500 is a synthetic peptide associated with the active region of thymosin beta-4 , a naturally occurring protein studied in cellular-migration, angiogenesis and wound-healing research. The two names are often used interchangeably in research discussion, though they are not strictly identical. As of 2026, TB-500 remains a research compound : supplied to laboratories as a reagent, labelled research use only, not for human consumption.
The usual confusion. “Not FDA approved” does not mean “banned” or “illegal to study.” It means TB-500 has not been authorised as a medicine for human use. Research-grade material is a separate category, and the legal line follows marketing and use, not the molecule alone.
The July 2026 FDA review: still not approval
On July 23, 2026, the FDA’s Pharmacy Compounding Advisory Committee is scheduled to discuss TB-500 bulk drug substances (free base and acetate), with wound healing listed as the evaluated use, as part of a review of several peptide-related substances for potential 503A Bulks List inclusion. The 503A list relates to traditional pharmacy compounding — not mass-market drug approval. A recommendation for inclusion would not make TB-500 an FDA-approved medicine. We cover the regenerative angle in detail in our BPC-157 and TB-500 FDA review.
Is TB-500 banned in sport?
Yes. The World Anti-Doping Agency (WADA) prohibits TB-500 and thymosin beta-4 at all times. Any athlete in a tested sport who uses it risks an anti-doping violation, independent of the compound’s research-use status. If you compete under WADA or a national anti-doping code, treat TB-500 as prohibited. (BPC-157 carries the same WADA prohibition — see Is BPC-157 banned?)
Why TB-500 isn’t approved
As with BPC-157, most of the TB-500 / thymosin beta-4 evidence base is pre-clinical rather than the large, controlled human trials approval demands. It is also a peptide with limited commercial-trial sponsorship, and regulators have raised characterisation and safety-data questions. That reflects where the formal evidence process stands, not a verdict on the underlying biology.
What this means if you research TB-500
Because TB-500 is not approved, responsible suppliers position it for laboratory research use only, not for human consumption, and back it with batch-specific testing. Look for a Certificate of Analysis confirming identity and purity, and treat any “FDA-approved TB-500” claim as a red flag — no such approval exists.
Frequently Asked Questions
Is TB-500 FDA approved? No. It is not an FDA-approved drug; it is a research-use-only peptide related to thymosin beta-4, not for human consumption.
Is TB-500 the same as thymosin beta-4? Closely related and often used interchangeably, but not strictly identical. Neither is FDA approved.
Is TB-500 banned in sport? Yes — WADA prohibits TB-500 and thymosin beta-4 at all times for tested athletes.
Related Reading
Source: the FDA’s July 23–24, 2026 Pharmacy Compounding Advisory Committee meeting agenda, and the WADA Prohibited List. External links are provided for research reference only; New-U is not affiliated with these organisations and links carry no endorsement either way.
From the Lab - Peptides on LinkedIn & Facebook
Lab-Verified Research Compounds
New-U Research Compounds supplies sealed 10-vial packs, independently verified by Janoshik and Freedom Diagnostics for >99% purity, with a Certificate of Analysis. Research use only - not for human consumption.
At New-U, we believe better conversations start with better information. For laboratory research use only. Not for human consumption.
Research-grade · >99% HPLC purity · COA per lot
Buy TB-500 from New-U Research Compounds
Lab-verified by Janoshik Analytical (RP-HPLC + ESI-MS), sealed vials, discreet tracked worldwide shipping. For laboratory research use only — not for human consumption.
PRECISION. PURITY. PERFORMANCE.
Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.
Shop
Research
Support
Ways to Pay
Shop by goal
Shop by compound
Shop by region
Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
© 2026 New-U Research Compounds · new-u.io